Sarcomatoid mesothelioma originating from mesothelioma in situ: are methylthioadenosine phosphorylase loss and CDKN2A homozygous deletion poor prognostic factors for preinvasive mesothelioma?
暂无分享,去创建一个
Y. Maniwa | T. Itoh | Yugo Tanaka | N. Jimbo | M. Tachihara | M. Nishikubo
[1] A. Nicholson,et al. The concept of mesothelioma in situ, with consideration of its potential impact on cytology diagnosis. , 2021, Pathology.
[2] S. Tamiya,et al. Development of mesothelioma in situ and its progression to invasive disease observed in a patient with uncontrolled pleural effusions for 15 years , 2020, Pathology international.
[3] L. Bubendorf,et al. Putative Malignant Pleural Mesothelioma in situ (MPMIS) with Sequential Acquisition of Genomic Alterations on Fluorescence in situ Hybridization (FISH) Examination , 2020, Acta Cytologica.
[4] Y. Maniwa,et al. Malignant mesothelioma in situ diagnosed by methylthioadenosine phosphorylase loss and homozygous deletion of CDKN2A: a case report , 2019, Virchows Archiv.
[5] F. Galateau-Sallé,et al. Malignant mesothelioma in situ: morphologic features and clinical outcome , 2019, Modern Pathology.
[6] S. Dacic,et al. Malignant mesothelioma in situ , 2018, Histopathology.
[7] K. Nabeshima,et al. Low homozygous/high heterozygous deletion status by p16 FISH correlates with a better prognostic group than high homozygous deletion status in malignant pleural mesothelioma. , 2016, Lung cancer.
[8] A. Gown,et al. Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group. , 2013, Archives of pathology & laboratory medicine.
[9] F. Galateau-Sallé,et al. The Separation of Benign and Malignant Mesothelial Proliferations , 2000, Archives of pathology & laboratory medicine.
[10] F. Galateau-Sallé,et al. Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas , 2008, Virchows Archiv.
[11] B. Robinson,et al. Advances in malignant mesothelioma. , 2005, The New England journal of medicine.
[12] M. Ladanyi,et al. Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[13] D. Henderson,et al. The concept of mesothelioma in situ: implications for diagnosis and histogenesis. , 1992, Seminars in diagnostic pathology.
[14] H. Bartsch,et al. International Agency for Research on Cancer. , 1969, WHO chronicle.